Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | LSS | P48449 | 13/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6400446 | 0.95 | MAPT (0.54) | MAPTNPC1PKMNFKB1MAOB | |
| SCHEMBL5637132 | 0.93 | TP53 (0.49) | MAPTNPC1PKMNFKB1MAOB | |
| SCHEMBL6399304 | 0.92 | LSS (0.55) | MAPTLSSKMT2AMEN1 | |
| SCHEMBL6399382 | 0.92 | LSS (0.55) | MAPTNPC1PKMNFKB1MAOB | |
| SCHEMBL6405963 | 0.91 | LSS (0.48) | MAOBLSSKMT2AMEN1 | |
| SCHEMBL5638776 | 0.89 | LSS (0.47) | MAPTNPC1PKMNFKB1MAOB | |
| SCHEMBL6401002 | 0.88 | LSS (0.49) | MAPTLSSKMT2ANOTUMMEN1 | |
| SCHEMBL5636791 | 0.88 | TP53 (0.47) | MAPTNPC1NFKB1RAB9ANFKB2 | |
| SCHEMBL6400584 | 0.88 | MAPT (0.51) | MAPTNPC1PKMNFKB1MAOB | |
| SCHEMBL6400220 | 0.87 | LSS (0.53) | LSSKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050020624-A1 | Dihydroindole and tetrahydroquinoline derivatives | AEBI JOHANNES (CH) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020624-A1 | Dihydroindole and tetrahydroquinoline derivatives | CYP46A1, LSS, CYP51A1 | MAPT 3562/4885NPC1 171/4885PKM 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.